Western Cape- Five suspects, one female and four males between the ages of 30 and 45 were arrested in Gugulethu for the unlawful possession of prohibited and unlicensed firearms and ammunition.
Limpopo traffic officer shoots and kills girlfriend, then kills himself A 45-year-old traffic officer from Bela-Bela municipality in Limpopo allegedly shot and killed his 30-year-old girlfriend with his service pistol on Tuesday before turning the gun on himself. Police spokesperson Brig Motlafela Mojapelo said the officer was reportedly on duty on the R101 when he left the scene. “According to information, the tragedy was discovered by a passing motorist who stopped next to the vehicle, apparently thinking the woman lying on the ground was the victim of an accident that might have just happened. When approaching the scene, the uniformed traffic officer sitting inside the vehicle allegedly shot himself dead,” Mojapelo said. The police were called and on arrival, the body of the woman was found on the ground next to the road, while the body of the officer was found in the vehicle. “People are urged to seek professional assistance when faced with domes
South African-American business tycoon Patrick Soon-Shiong has announced the launch of an SA Covid-19 and cancer vaccine initiative. Soon-Shiong and President Cyril Ramaphosa revealed the ambitious initiative during a virtual press briefing on Thursday. It is a partnership between NantWorks LCC, the Council for Scientific and Industrial Research (CSIR), SA Medical Research Council (SAMRC), Centre for Epidemic Response and Innovation (CERI), and the universities of Cape Town, Witwatersrand, Stellenbosch and KwaZulu-Natal. Soon-Shiong is a billionaire, bioscientist and media guru. He is renowned for inventing the drug Abraxane, known for its efficiency in treating lung, breast and pancreatic cancer. The collaboration agreement will initiate the “transfer of biologic manufacturing technology for Covid-19 and cancer vaccines and next-generation cell-based immunotherapies. This will enable the rapid clinical development of next-generation vaccines for infectious diseases and cancer at cent
Comments